SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-051294
Filing Date
2020-04-27
Accepted
2020-04-27 07:30:23
Documents
4
Period of Report
2020-06-01
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2016707-1_def14a.htm DEF 14A 553724
2 GRAPHIC lg_akero-4c.jpg GRAPHIC 241855
3 GRAPHIC tm2016707d1-pc_01akerobw.jpg GRAPHIC 773755
4 GRAPHIC tm2016707d1-pc_02akero4c.jpg GRAPHIC 425191
  Complete submission text file 0001104659-20-051294.txt   2492604
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38944 | Film No.: 20817233
SIC: 2834 Pharmaceutical Preparations